Taylor Hoffman Wealth Management’s AbbVie ABBV Stock Holding History

Taylor Hoffman Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,827	Closed	-$179K	–	119
2020 Q2	$179K	Buy	+1,827	New	+$161K	0.11%	122
2020 Q1	–	Sell	-1,228	Closed	-$109K	–	109
2019 Q4	$109K	Hold	1,228	–	–	0.07%	154
2019 Q3	$93K	Hold	1,228	–	–	0.07%	157
2019 Q2	$89K	Hold	1,228	–	–	0.07%	156
2019 Q1	$99K	Hold	1,228	–	–	0.07%	144
2018 Q4	$113K	Sell	1,228 -400	-25%	-$35.2K	0.1%	126
2018 Q3	$154K	Hold	1,628	–	–	0.12%	112
2018 Q2	$151K	Hold	1,628	–	–	0.13%	112
2018 Q1	$154K	Hold	1,628	–	–	0.14%	112
2017 Q4	$157K	Buy	+1,628	New	+$153K	0.15%	106

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Taylor Hoffman Wealth Management's ABBV Position: Q3 2020 in Review

Taylor Hoffman Wealth Management sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 1,827 shares — an estimated $179K sold.

Taylor Hoffman Wealth Management first reported a position in ABBV in Q4 2017 and held it in 10 quarters. The position peaked at $179K in Q2 2020. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

Taylor Hoffman Wealth Management reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
Taylor Hoffman Wealth Management sold 1,827 AbbVie shares in Q3 2020, an estimated $179K.
Taylor Hoffman Wealth Management first reported a position in AbbVie in Q4 2017 and held it in 10 quarters.
Taylor Hoffman Wealth Management's AbbVie position peaked at $179K in Q2 2020.
2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Taylor Hoffman Wealth Management's 13F filing for Q3 2020, filed 29 Oct 2020.